Beta Bionics, Inc. (BBNX) vs SL Science Holding Ltd (SLBT)
A side-by-side comparison of Beta Bionics, Inc. and SL Science Holding Ltd across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BBNX
Beta Bionics, Inc.
$18.63HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
SLBT
SL Science Holding Ltd
$1.52HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT
Total return — BBNX vs SLBT
growth of $100 · dividends reinvested · last 1yBBNX +101.6% (+101.6%/yr)SLBT -79.6% (-79.6%/yr)BBNX compounded faster over this window
Log scale — wide-divergence pair
BBNX SLBT
BBNX vs SLBT: by the numbers
- •SLBT is the larger company ($852M vs $838M market cap).
- •Both run net losses; BBNX's is the smaller (-61.32% vs -173.85% net margin).
Metrics side by side
Valuation
| Metric | BBNX | SLBT |
|---|---|---|
| P/S ratio | 7.04 | N/A |
| P/B ratio | 3.27 | 373.20 |
Profitability
| Metric | BBNX | SLBT |
|---|---|---|
| Gross margin | 58.31% | 35.27% |
| Operating margin | -69.75% | -174.65% |
| Net margin | -61.32% | -173.85% |
| ROE | -28.46% | -167.25% |
| ROIC | -31.17% | -163.39% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.